EMILY KWONG, HOST:
You're listening to SHORT WAVE...
(SOUNDBITE OF MUSIC)
KWONG: ...from NPR.
There was a big announcement in January from the FDA. They were accelerating approval for a drug called lecanemab.
(SOUNDBITE OF ARCHIVED RECORDING)
SCOTT SIMON, BYLINE: The U.S. Food and Drug Administration has approved a drug that appears to slow down the progression of Alzheimer's disease.
KWONG: Now, in clinical trials, lecanemab's effects on early Alzheimer's disease were pretty small. Among the hundreds of patients who . . .
Black Hot Fire Network
November 28, 2023